{"protocolSection":{"identificationModule":{"nctId":"NCT05364931","orgStudyIdInfo":{"id":"D5671C00006"},"secondaryIdInfos":[{"id":"2021-005484-53","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"AstraZeneca","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis","officialTitle":"A Phase II Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Cotadutide in Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis","acronym":"PROXYMO-ADV"},"statusModule":{"statusVerifiedDate":"2025-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-07-14","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-04-19","type":"ACTUAL"},"completionDateStruct":{"date":"2024-04-19","type":"ACTUAL"},"studyFirstSubmitDate":"2022-05-04","studyFirstSubmitQcDate":"2022-05-04","studyFirstPostDateStruct":{"date":"2022-05-06","type":"ACTUAL"},"resultsFirstSubmitDate":"2025-04-16","resultsFirstSubmitQcDate":"2025-08-14","resultsFirstPostDateStruct":{"date":"2025-09-03","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-08-14","lastUpdatePostDateStruct":{"date":"2025-09-03","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"AstraZeneca","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic NASH with fibrosis.","detailedDescription":"A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of cotadutide at 300 and 600 μg in participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis."},"conditionsModule":{"conditions":["Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis"],"keywords":["NASH","fatty liver disease","non-alcoholic fatty liver","NAS","liver fibrosis","Non-alcoholic steatohepatitis"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":54,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Cotadutide 300μg","type":"EXPERIMENTAL","interventionNames":["Drug: Cotadutide"]},{"label":"Placebo 300μg","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Cotadutide 600μg","type":"EXPERIMENTAL","interventionNames":["Drug: Cotadutide"]},{"label":"Placebo 600μg","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"Cotadutide","description":"Cotadutide administered subcutaneously once daily","armGroupLabels":["Cotadutide 300μg","Cotadutide 600μg"]},{"type":"DRUG","name":"Placebo","description":"Placebo administered subcutaneously once daily","armGroupLabels":["Placebo 300μg","Placebo 600μg"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With Adverse Events (AEs).","description":"To assess safety and tolerability of Cotadutide. Occurrence of AEs and serious AEs, including AEs leading to dose reduction, and AEs of special interest.","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks."},{"measure":"Number of Participants With Abnormal Vital Signs.","description":"To assess safety and tolerability of Cotadutide.","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks."},{"measure":"Number of Participants With Abnormal Laboratory Assessments","description":"To assess safety and tolerability of Cotadutide.","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks."},{"measure":"Number of Participants With Treatment Emergent Abnormality in 12-lead Electrocardiogram (ECG).","description":"To assess safety and tolerability of Cotadutide.","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks."},{"measure":"Number of Treatment-induced Anti-Drug Antibody (ADA) Participants","description":"To assess the immunogenicity of Cotadutide","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks."},{"measure":"Titer of Treatment-induced Anti-Drug Antibody (ADA)","description":"To assess the immunogenicity of cotadutide. Titers represent a dilution and are therefore unitless. Summary statistics are based on the maximum observed titer for each ADA positive subject within the time frame.","timeFrame":"From first dose on Day 1 until the follow-up period, 28 days post last dose (from randomization up to approximately 52 weeks)."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Provision of informed consent\n2. Males and female participants ≥ 18 to ≤ 75 years of age (inclusive) at the time of signing the informed consent.\n3. Histologically confirmed non-alcoholic steatohepatitis (NASH) per NASH Clinical Research Network (CRN) criteria as diagnosed by histology from a liver biopsy performed ≤ 180 days from randomization and fulfilling all of the following histological criteria:\n\n   1. NAS (Non-alcoholic Fatty Liver Disease Activity Score) ≥ 4 with a score of ≥ 1 for each component: steatosis, lobular inflammation, and ballooning\n   2. Presence of fibrosis stage F2 or F3\n4. Women of childbearing potential, non-pregnant and nonbreastfeeding and using appropriate birth control to avoid pregnancy throughout the study and for up to 4 weeks after the last dose of study intervention.\n\nExclusion Criteria:\n\n1. Chronic liver disease of other etiologies.\n2. History of cirrhosis and/or hepatic decompensation, including evidence of portal hypertension (e.g. low platelet count, splenomegaly, ascites, history of hepatic encephalopathy, esophageal varices, or variceal bleeding).\n3. Clinically significant cardiovascular or cerebrovascular disease within 90 days prior to screening, including but not limited to, myocardial infarction, acute coronary syndrome, unstable angina pectoris, transient ischemic attack, or stroke, or participants who have undergone percutaneous coronary intervention or a coronary artery bypass graft within the past 90 days or who are due to undergo these procedures at the time of screening\n4. History of malignant neoplasms within 5 years prior to screening, except for adequately treated basal cell, squamous cell skin cancer, or any in situ carcinoma.\n5. Participation in another clinical study with an investigational product administered within the last 30 days or 5 half-lives of the therapy (whichever is longer) at the time of screening or the time of the historical biopsy or concurrent participation in another interventional study of any kind or prior randomization in this study.\n6. Severe allergy/hypersensitivity to any of the proposed study treatments or excipients\n7. Contraindication to liver biopsy (eg, bleeding diathesis, such as hemophilia, suspected hemangioma, or suspected echinococcal infection) or inability to safely obtain a liver biopsy as determined by the investigator\n8. Severely uncontrolled hypertension defined as SBP ≥ 180 mmHg or DBP ≥ 110 mmHg on the average of 2 seated BP measurements after being at rest for at least 10 minutes at screening or randomization 9 Any positive results for human immunodeficiency virus infection, positive results for hepatitis B surface antigen or hepatitis C antibody test along with a positive HCV RNA test.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Research Site","city":"Tucson","state":"Arizona","zip":"85712","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"Research Site","city":"Canoga Park","state":"California","zip":"91303","country":"United States","geoPoint":{"lat":34.20112,"lon":-118.59814}},{"facility":"Research Site","city":"Gilroy","state":"California","zip":"95020","country":"United States","geoPoint":{"lat":37.00578,"lon":-121.56828}},{"facility":"Research Site","city":"Sacramento","state":"California","zip":"95821","country":"United States","geoPoint":{"lat":38.58157,"lon":-121.4944}},{"facility":"Research Site","city":"Englewood","state":"Colorado","zip":"80113","country":"United States","geoPoint":{"lat":39.64777,"lon":-104.98776}},{"facility":"Research Site","city":"Bradenton","state":"Florida","zip":"34208","country":"United States","geoPoint":{"lat":27.49893,"lon":-82.57482}},{"facility":"Research Site","city":"Homestead","state":"Florida","zip":"33032","country":"United States","geoPoint":{"lat":25.46872,"lon":-80.47756}},{"facility":"Research Site","city":"Jacksonville","state":"Florida","zip":"32216","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"Research Site","city":"Miami","state":"Florida","zip":"33175","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Research Site","city":"Miami","state":"Florida","zip":"33176","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Research Site","city":"Winter Park","state":"Florida","zip":"32789","country":"United States","geoPoint":{"lat":28.6,"lon":-81.33924}},{"facility":"Research Site","city":"Munster","state":"Indiana","zip":"46321","country":"United States","geoPoint":{"lat":41.56448,"lon":-87.51254}},{"facility":"Research Site","city":"Houma","state":"Louisiana","zip":"70363","country":"United States","geoPoint":{"lat":29.59577,"lon":-90.71953}},{"facility":"Research Site","city":"Marrero","state":"Louisiana","zip":"70006","country":"United States","geoPoint":{"lat":29.89937,"lon":-90.10035}},{"facility":"Research Site","city":"Marrero","state":"Louisiana","zip":"70072","country":"United States","geoPoint":{"lat":29.89937,"lon":-90.10035}},{"facility":"Research Site","city":"Shreveport","state":"Louisiana","zip":"71105","country":"United States","geoPoint":{"lat":32.52515,"lon":-93.75018}},{"facility":"Research Site","city":"Ann Arbor","state":"Michigan","zip":"48109","country":"United States","geoPoint":{"lat":42.27756,"lon":-83.74088}},{"facility":"Research Site","city":"Las Vegas","state":"Nevada","zip":"89104","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Research Site","city":"Las Vegas","state":"Nevada","zip":"89109","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Research Site","city":"Lawrence","state":"New Jersey","zip":"08648","country":"United States","geoPoint":{"lat":40.274,"lon":-74.6796}},{"facility":"Research Site","city":"Warren Township","state":"New Jersey","zip":"07059","country":"United States","geoPoint":{"lat":40.60822,"lon":-74.51803}},{"facility":"Research Site","city":"Morehead City","state":"North Carolina","zip":"28557","country":"United States","geoPoint":{"lat":34.72294,"lon":-76.72604}},{"facility":"Research Site","city":"Chattanooga","state":"Tennessee","zip":"37421","country":"United States","geoPoint":{"lat":35.04563,"lon":-85.30968}},{"facility":"Research Site","city":"Arlington","state":"Texas","zip":"76012","country":"United States","geoPoint":{"lat":32.73569,"lon":-97.10807}},{"facility":"Research Site","city":"Austin","state":"Texas","zip":"78745","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Research Site","city":"Dallas","state":"Texas","zip":"75230","country":"United States","geoPoint":{"lat":32.78306,"lon":-96.80667}},{"facility":"Research Site","city":"Lewisville","state":"Texas","zip":"75057","country":"United States","geoPoint":{"lat":33.04623,"lon":-96.99417}},{"facility":"Research Site","city":"San Antonio","state":"Texas","zip":"78215","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Research Site","city":"Ogden","state":"Utah","zip":"84403","country":"United States","geoPoint":{"lat":41.223,"lon":-111.97383}},{"facility":"Research Site","city":"CABA","zip":"C1056ABJ","country":"Argentina"},{"facility":"Research Site","city":"Heidelberg","zip":"3084","country":"Australia","geoPoint":{"lat":-37.75,"lon":145.06667}},{"facility":"Research Site","city":"Kogarah","zip":"2217","country":"Australia","geoPoint":{"lat":-33.9681,"lon":151.13564}},{"facility":"Research Site","city":"Meadowbrook","zip":"4131","country":"Australia","geoPoint":{"lat":-27.66401,"lon":153.14465}},{"facility":"Research Site","city":"Melbourne","zip":"3004","country":"Australia","geoPoint":{"lat":-37.814,"lon":144.96332}},{"facility":"Research Site","city":"Westmead","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"Research Site","city":"Vienna","zip":"1030","country":"Austria","geoPoint":{"lat":48.20849,"lon":16.37208}},{"facility":"Research Site","city":"Vienna","zip":"1130","country":"Austria","geoPoint":{"lat":48.20849,"lon":16.37208}},{"facility":"Research Site","city":"London","state":"Ontario","zip":"N6A 5A5","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"Research Site","city":"Terrebonne","state":"Quebec","zip":"J6X 4P7","country":"Canada","geoPoint":{"lat":45.70004,"lon":-73.64732}},{"facility":"Research Site","city":"Montpellier","zip":"34090","country":"France","geoPoint":{"lat":43.61093,"lon":3.87635}},{"facility":"Research Site","city":"Paris","zip":"75651","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"Research Site","city":"Dresden","zip":"01307","country":"Germany","geoPoint":{"lat":51.05089,"lon":13.73832}},{"facility":"Research Site","city":"Konstanz","zip":"78464","country":"Germany","geoPoint":{"lat":47.66033,"lon":9.17582}},{"facility":"Research Site","city":"Athens","zip":"12462","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"Research Site","city":"Ioannina","zip":"45500","country":"Greece","geoPoint":{"lat":39.66341,"lon":20.85187}},{"facility":"Research Site","city":"Haifa","zip":"34362","country":"Israel","geoPoint":{"lat":32.81303,"lon":34.99928}},{"facility":"Research Site","city":"Jerusalem","zip":"91031","country":"Israel","geoPoint":{"lat":31.76904,"lon":35.21633}},{"facility":"Research Site","city":"Nahariya","zip":"22100","country":"Israel","geoPoint":{"lat":33.00892,"lon":35.09814}},{"facility":"Research Site","city":"Petah Tikva","zip":"49100","country":"Israel","geoPoint":{"lat":32.0888,"lon":34.88666}},{"facility":"Research Site","city":"Tel Aviv","zip":"64239","country":"Israel","geoPoint":{"lat":32.08088,"lon":34.78057}},{"facility":"Research Site","city":"Tel Litwinsky","zip":"52621","country":"Israel","geoPoint":{"lat":32.05096,"lon":34.84588}},{"facility":"Research Site","city":"Catania","zip":"95100","country":"Italy","geoPoint":{"lat":37.49223,"lon":15.07041}},{"facility":"Research Site","city":"Foggia","zip":"71100","country":"Italy","geoPoint":{"lat":41.45845,"lon":15.55188}},{"facility":"Research Site","city":"Milan","zip":"20127","country":"Italy","geoPoint":{"lat":42.78235,"lon":12.59836}},{"facility":"Research Site","city":"Roma","zip":"00100","country":"Italy","geoPoint":{"lat":44.99364,"lon":11.10642}},{"facility":"Research Site","city":"Roma","zip":"00161","country":"Italy","geoPoint":{"lat":44.99364,"lon":11.10642}},{"facility":"Research Site","city":"Rozzano","zip":"20089","country":"Italy","geoPoint":{"lat":45.38193,"lon":9.1559}},{"facility":"Research Site","city":"San Giovanni Rotondo","zip":"71013","country":"Italy","geoPoint":{"lat":41.70643,"lon":15.7277}},{"facility":"Research Site","city":"Chiba","zip":"260-8677","country":"Japan","geoPoint":{"lat":35.6,"lon":140.11667}},{"facility":"Research Site","city":"Fukui-shi","zip":"918-8503","country":"Japan","geoPoint":{"lat":36.06443,"lon":136.22257}},{"facility":"Research Site","city":"Gifu","zip":"500-8513","country":"Japan","geoPoint":{"lat":35.42291,"lon":136.76039}},{"facility":"Research Site","city":"Hiroshima","zip":"734-8551","country":"Japan","geoPoint":{"lat":34.4,"lon":132.45}},{"facility":"Research Site","city":"Kawasaki-shi","zip":"215-0026","country":"Japan"},{"facility":"Research Site","city":"Kawasaki-shi","zip":"216-8511","country":"Japan"},{"facility":"Research Site","city":"Kure-shi","zip":"737-0023","country":"Japan"},{"facility":"Research Site","city":"Osaka","zip":"637086","country":"Japan","geoPoint":{"lat":34.69379,"lon":135.50107}},{"facility":"Research Site","city":"Saga","zip":"849-8501","country":"Japan","geoPoint":{"lat":33.23333,"lon":130.3}},{"facility":"Research Site","city":"Sapporo","zip":"062-0921","country":"Japan","geoPoint":{"lat":43.06667,"lon":141.35}},{"facility":"Research Site","city":"Sendai","zip":"980-0873","country":"Japan","geoPoint":{"lat":38.26667,"lon":140.86667}},{"facility":"Research Site","city":"Shinjuku-ku","zip":"160-0023","country":"Japan"},{"facility":"Research Site","city":"Suita-shi","zip":"564-0013","country":"Japan"},{"facility":"Research Site","city":"Takasaki-shi","zip":"370-0829","country":"Japan"},{"facility":"Research Site","city":"Toon-shi","zip":"791-0281","country":"Japan"},{"facility":"Research Site","city":"Yokohama","zip":"236-0004","country":"Japan","geoPoint":{"lat":35.43333,"lon":139.65}},{"facility":"Research Site","city":"Yokohama","zip":"245-8575","country":"Japan","geoPoint":{"lat":35.43333,"lon":139.65}},{"facility":"Research Site","city":"Kuala Lumpur","zip":"56000","country":"Malaysia","geoPoint":{"lat":3.1412,"lon":101.68653}},{"facility":"Research Site","city":"Kuala Lumpur","zip":"59100","country":"Malaysia","geoPoint":{"lat":3.1412,"lon":101.68653}},{"facility":"Research Site","city":"Malacca","zip":"75400","country":"Malaysia","geoPoint":{"lat":2.196,"lon":102.2405}},{"facility":"Research Site","city":"Seremban","zip":"70300","country":"Malaysia","geoPoint":{"lat":2.7297,"lon":101.9381}},{"facility":"Research Site","city":"Auckland","zip":"2025","country":"New Zealand","geoPoint":{"lat":-36.84853,"lon":174.76349}},{"facility":"Research Site","city":"Christchurch","zip":"8011","country":"New Zealand","geoPoint":{"lat":-43.53333,"lon":172.63333}},{"facility":"Research Site","city":"Grafton","zip":"1023","country":"New Zealand","geoPoint":{"lat":-36.86029,"lon":174.76566}},{"facility":"Research Site","city":"Plumstead","zip":"7800","country":"South Africa","geoPoint":{"lat":-34.01909,"lon":18.47835}},{"facility":"Research Site","city":"Busan","zip":"49241","country":"South Korea","geoPoint":{"lat":35.10168,"lon":129.03004}},{"facility":"Research Site","city":"Gangwon-do","zip":"26426","country":"South Korea"},{"facility":"Research Site","city":"Junggu","zip":"41944","country":"South Korea","geoPoint":{"lat":37.69175,"lon":126.60024}},{"facility":"Research Site","city":"Seoul","zip":"03080","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Research Site","city":"Seoul","zip":"04763","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Research Site","city":"Seoul","zip":"06351","country":"South Korea","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Research Site","city":"A Coruña","zip":"15006","country":"Spain","geoPoint":{"lat":43.37135,"lon":-8.396}},{"facility":"Research Site","city":"Almería","zip":"04009","country":"Spain","geoPoint":{"lat":36.83814,"lon":-2.45974}},{"facility":"Research Site","city":"Lleida","zip":"25198","country":"Spain","geoPoint":{"lat":41.61674,"lon":0.62218}},{"facility":"Research Site","city":"Madrid","zip":"28046","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Research Site","city":"Málaga","zip":"29010","country":"Spain","geoPoint":{"lat":36.72016,"lon":-4.42034}},{"facility":"Research Site","city":"Seville","zip":"41013","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"Research Site","city":"Kaohsiung City","zip":"80756","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"Research Site","city":"Tainan","zip":"70403","country":"Taiwan","geoPoint":{"lat":22.99083,"lon":120.21333}},{"facility":"Research Site","city":"Taipei","zip":"110","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"Research Site","city":"Taipei","zip":"11217","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"Research Site","city":"Taipei","zip":"114","country":"Taiwan","geoPoint":{"lat":25.05306,"lon":121.52639}},{"facility":"Research Site","city":"Bangkok","zip":"10330","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Research Site","city":"Bangkok","zip":"10400","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Research Site","city":"Bangkok","zip":"10700","country":"Thailand","geoPoint":{"lat":13.75398,"lon":100.50144}},{"facility":"Research Site","city":"Hat Yai","zip":"90110","country":"Thailand","geoPoint":{"lat":7.00836,"lon":100.47668}},{"facility":"Research Site","city":"Khon Kaen","zip":"40002","country":"Thailand","geoPoint":{"lat":16.44671,"lon":102.833}},{"facility":"Research Site","city":"Ankara","zip":"06800","country":"Turkey (Türkiye)","geoPoint":{"lat":39.91987,"lon":32.85427}},{"facility":"Research Site","city":"Istanbul","zip":"34093","country":"Turkey (Türkiye)","geoPoint":{"lat":41.01384,"lon":28.94966}},{"facility":"Research Site","city":"Aberdeen","zip":"AB25 2ZN","country":"United Kingdom","geoPoint":{"lat":57.14369,"lon":-2.09814}},{"facility":"Research Site","city":"Glasgow","zip":"G51 4LB","country":"United Kingdom","geoPoint":{"lat":55.86515,"lon":-4.25763}},{"facility":"Research Site","city":"Ipswich","zip":"IP4 5PD","country":"United Kingdom","geoPoint":{"lat":52.05917,"lon":1.15545}},{"facility":"Research Site","city":"Liverpool","zip":"L1 9ED","country":"United Kingdom","geoPoint":{"lat":53.41058,"lon":-2.97794}},{"facility":"Research Site","city":"London","zip":"EN1 1LJ","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"Research Site","city":"Preston","zip":"PR2 9QB","country":"United Kingdom","geoPoint":{"lat":53.76282,"lon":-2.70452}},{"facility":"Research Site","city":"Rochdale","zip":"OL11 4AU","country":"United Kingdom","geoPoint":{"lat":53.61766,"lon":-2.1552}},{"facility":"Research Site","city":"Sheffield","zip":"S2 5FX","country":"United Kingdom","geoPoint":{"lat":53.38297,"lon":-1.4659}}]},"referencesModule":{"seeAlsoLinks":[{"label":"Redacted CSP","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5671C00006&amp;attachmentIdentifier=ab9ab43f-7d52-4826-b285-72457171d41c&amp;fileName=D5671C00006_Redacted_CSP.pdf&amp;versionIdentifier="},{"label":"Redacted SAP","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5671C00006&amp;attachmentIdentifier=1a7fca5f-0c40-449c-9b26-d1bec5b2b93e&amp;fileName=D5671C00006_Redacted_SAP.pdf&amp;versionIdentifier="},{"label":"Redacted CSR Synopsis","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5671C00006&amp;attachmentIdentifier=dde044fc-40da-4b3d-8a06-31550cf76396&amp;fileName=D5671C00006_Redacted_CSR_Synopsis.pdf&amp;versionIdentifier="}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment:\n\nhttps://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.","infoTypes":["STUDY_PROTOCOL","SAP"],"timeFrame":"AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.","accessCriteria":"When a request has been approved AstraZeneca will provide access to the deidentified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.","url":"https://astrazenecagroup-dt.pharmacm.com/DT/Home"}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"FG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"FG002","title":"Placebo 600 ug","description":"Placebo 600 ug QD"},{"id":"FG003","title":"Placebo 300 ug","description":"Placebo 300 ug QD"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"17"},{"groupId":"FG001","numSubjects":"18"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"10"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"14"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"8"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"4"},{"groupId":"FG003","numSubjects":"2"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"2"}]},{"type":"study terminated by sponsor (reason as collected in database, study was not terminated)","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}]},{"type":"Discontinued","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"Although there are two placebo arms for blinding purposes, the safety and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group.","groups":[{"id":"BG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"BG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"BG002","title":"Placebo 600 ug","description":"Placebo 600 ug QD"},{"id":"BG003","title":"Placebo 300 ug","description":"Placebo 300 ug QD"},{"id":"BG004","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"54"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"title":"Mean(standard Deviation)","categories":[{"measurements":[{"groupId":"BG000","value":"54.4","spread":"12.4"},{"groupId":"BG001","value":"53","spread":"12.6"},{"groupId":"BG002","value":"56.4","spread":"9.4"},{"groupId":"BG003","value":"56.9","spread":"11.6"},{"groupId":"BG004","value":"54.7","spread":"11.7"}]}]}]},{"title":"Age, Customized","populationDescription":"The full analysis set population","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":">= 65 years","categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"13"}]}]},{"title":">=50 - <65 years","categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"23"}]}]},{"title":"< 50 years","categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"18"}]}]}]},{"title":"Sex: Female, Male","populationDescription":"The full analysis set population","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"31"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"23"}]}]}]},{"title":"Race/Ethnicity, Customized","populationDescription":"The full analysis set population","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"American Indian or Alaska Native","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"}]}]},{"title":"Asian","categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"18"}]}]},{"title":"Black or African American","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}]}]},{"title":"Multiple","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]}]},{"title":"Native Hawaiian or Other Pacific Islander","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]}]},{"title":"Not Reported","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"}]}]},{"title":"Other","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}]}]},{"title":"White","categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"7"},{"groupId":"BG004","value":"32"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Events (AEs).","description":"To assess safety and tolerability of Cotadutide. Occurrence of AEs and serious AEs, including AEs leading to dose reduction, and AEs of special interest.","populationDescription":"Although there are two placebo arms for blinding purposes, the safety, immunogenicity, and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group as prespecified in the SAP.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks.","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 300 ug QD"},{"id":"OG002","title":"Placebo","description":"Placebo 300 ug or 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"13"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Abnormal Vital Signs.","description":"To assess safety and tolerability of Cotadutide.","populationDescription":"Although there are two placebo arms for blinding purposes, the safety and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group as prespecified in the SAP.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks.","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"OG002","title":"Placebo","description":"Placebo 300 ug or 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"17"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Abnormal Laboratory Assessments","description":"To assess safety and tolerability of Cotadutide.","populationDescription":"Although there are two placebo arms for blinding purposes, the safety and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group as prespecified in the SAP.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks.","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"OG002","title":"Placebo","description":"Placebo 300 ug or 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"19"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Treatment Emergent Abnormality in 12-lead Electrocardiogram (ECG).","description":"To assess safety and tolerability of Cotadutide.","populationDescription":"Although there are two placebo arms for blinding purposes, the safety and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group as prespecified in the SAP.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks.","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"OG002","title":"Placebo","description":"Placebo 300 ug or 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"}]}]}]},{"type":"PRIMARY","title":"Number of Treatment-induced Anti-Drug Antibody (ADA) Participants","description":"To assess the immunogenicity of Cotadutide","populationDescription":"Although there are two placebo arms for blinding purposes, the safety and efficacy analyses in the (abbreviated) CSR pooled the two placebo arms and analyzed them as a single group as prespecified in the SAP.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"First dose on Day 1 until the follow-up period, 28 days post last dose, up to approximately 52 weeks.","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"},{"id":"OG002","title":"Placebo","description":"Placebo 300 ug or 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"19"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"PRIMARY","title":"Titer of Treatment-induced Anti-Drug Antibody (ADA)","description":"To assess the immunogenicity of cotadutide. Titers represent a dilution and are therefore unitless. Summary statistics are based on the maximum observed titer for each ADA positive subject within the time frame.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"titer","timeFrame":"From first dose on Day 1 until the follow-up period, 28 days post last dose (from randomization up to approximately 52 weeks).","groups":[{"id":"OG000","title":"Cotadutide 300 ug","description":"Cotadutide 300 ug QD"},{"id":"OG001","title":"Cotadutide 600 ug","description":"Cotadutide 600 ug QD"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"18"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"240","lowerLimit":"15","upperLimit":"7680"},{"groupId":"OG001","value":"60","lowerLimit":"15","upperLimit":"240"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"1","timeFrame":"From first dose on Day 1 up to approximately 52 weeks.","eventGroups":[{"id":"EG000","title":"Cotadutide 300 ug","description":"Description (Arm-group)","deathsNumAffected":1,"deathsNumAtRisk":17,"seriousNumAffected":1,"seriousNumAtRisk":17,"otherNumAffected":16,"otherNumAtRisk":17},{"id":"EG001","title":"Cotadutide 600 ug","description":"Description (Arm-group)","deathsNumAffected":0,"deathsNumAtRisk":18,"seriousNumAffected":0,"seriousNumAtRisk":18,"otherNumAffected":17,"otherNumAtRisk":18},{"id":"EG002","title":"Placebo 600 ug","description":"Description (Arm-group)","deathsNumAffected":0,"deathsNumAtRisk":9,"seriousNumAffected":0,"seriousNumAtRisk":9,"otherNumAffected":5,"otherNumAtRisk":9},{"id":"EG003","title":"Placebo 300 ug","description":"Description (Arm-group)","deathsNumAffected":0,"deathsNumAtRisk":10,"seriousNumAffected":0,"seriousNumAtRisk":10,"otherNumAffected":8,"otherNumAtRisk":10}],"seriousEvents":[{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Pacemaker generated arrhythmia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Atrioventricular block second degree","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]}],"otherEvents":[{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":17},{"groupId":"EG001","numEvents":7,"numAffected":3,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Dry mouth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Flatulence","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Food poisoning","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Gastrointestinal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":17},{"groupId":"EG001","numEvents":14,"numAffected":9,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Umbilical hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":17},{"groupId":"EG001","numEvents":8,"numAffected":6,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Early satiety","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Exercise tolerance decreased","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Face oedema","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Injection site bruising","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Injection site haemorrhage","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Injection site pruritus","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Injection site reaction","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":10}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Gallbladder polyp","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Covid-19","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Folliculitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Gingivitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Helicobacter gastritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Vulvovaginal candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Epicondylitis","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Palpitations","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Immunisation reaction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Amylase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Blood cholesterol increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Sinus tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Blood pressure increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Gamma-glutamyltransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Glycosylated haemoglobin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Lipase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Weight decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":17},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Folate deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Hyperamylasaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":3,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Increased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Excessive cerumen production","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Iron deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Type 2 diabetes mellitus","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Vitamin b12 deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Vitamin d deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Flank pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Intervertebral disc degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Osteopenia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Tendon disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":10}]},{"term":"Lethargy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Somnolence","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Testicular pain","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Obstructive sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Sinus congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Onychoclasis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":10}]},{"term":"Vitiligo","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":18},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 26.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":17},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":18},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":10}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Global Clinical Lead","organization":"AstraZeneca","email":"information.center@astrazeneca.com","phone":"1-877-240-9479"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2023-05-15","uploadDate":"2025-04-16T04:11","filename":"Prot_000.pdf","size":1030480},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2024-05-17","uploadDate":"2025-04-16T04:12","filename":"SAP_001.pdf","size":888850}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-10-09","removedCountries":["Belgium","Brazil","Chile","China","Colombia","Hong Kong","Hungary","Mexico","Netherlands","Peru","Philippines","Puerto Rico","Singapore","Switzerland","Vietnam"],"submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2025-05-02","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D065626","term":"Non-alcoholic Fatty Liver Disease"},{"id":"D008103","term":"Liver Cirrhosis"}],"ancestors":[{"id":"D005234","term":"Fatty Liver"},{"id":"D008107","term":"Liver Diseases"},{"id":"D004066","term":"Digestive System Diseases"},{"id":"D005355","term":"Fibrosis"},{"id":"D010335","term":"Pathologic Processes"},{"id":"D013568","term":"Pathological Conditions, Signs and Symptoms"}]},"interventionBrowseModule":{"meshes":[{"id":"C000624433","term":"cotadutide"}]}},"hasResults":true}